Literature DB >> 15219221

Prothrombin G20210A mutation, and not factor V Leiden mutation, is a risk factor for cerebral venous thrombosis in Brazilian patients.

C A Rodrigues, L K A Rocha, V M Morelli, R F Franco, D M Lourenço.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15219221     DOI： 10.1111/j.1538-7836.2004.00785.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  4 in total

1.  Increased Factor V Leiden frequency is associated with venous thrombotic events among young Brazilian patients.

Authors:  Adriano de Paula Sabino; Daniela Amorim Melgaço Guimarães; Daniel Dias Ribeiro; Sabrina Guimarães Paiva; Luci Maria Sant'Ana Dusse; Maria das Graças Carvalho; Ana Paula Fernandes
Journal:  J Thromb Thrombolysis       Date:  2007-03-31       Impact factor: 2.300

Review 2.  Hormonal contraceptives and cerebral venous thrombosis risk: a systematic review and meta-analysis.

Authors:  Farnaz Amoozegar; Paul E Ronksley; Reg Sauve; Bijoy K Menon
Journal:  Front Neurol       Date:  2015-02-02       Impact factor: 4.003

Review 3.  Prevalence and Geographical Variation of Prothrombin G20210A Mutation in Patients with Cerebral Vein Thrombosis: A Systematic Review and Meta-Analysis.

Authors:  Joaquín V Gonzalez; Andrés G Barboza; Fernando J Vazquez; Esteban Gándara
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

4.  Factor V Leiden, factor V Cambridge, factor II GA20210, and methylenetetrahydrofolate reductase in cerebral venous and sinus thrombosis: A case-control study.

Authors:  Mohammad Saadatnia; Mansour Salehi; Ahmad Movahedian; Seyed Ziaeddin Samsam Shariat; Mehri Salari; Marzieh Tajmirriahi; Elham Asadimobarakeh; Rasoul Salehi; Gilda Amini; Homa Ebrahimi; Ehsan Kheradmand
Journal:  J Res Med Sci       Date:  2015-06       Impact factor: 1.852
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.